Drug recall · November 5, 2014
APLENZIN¿ recall
Why: Labeling: Incorrect or Missing Package Insert
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.
- Lots / codes
Lot # 13E019P; Exp 03/17
- Quantity
- 20,499 HDPE bottles
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- June 5, 2014 · Voluntary: Firm initiated
- Classified
- October 28, 2014
- Reported
- November 5, 2014
- Ended
- July 27, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.